Overview

Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the use of sodium valproate is effective in slowing the disease progression in Amyotrophic Lateral Sclerosis.
Phase:
Phase 3
Details
Lead Sponsor:
UMC Utrecht
Collaborator:
Princess Beatrix Muscle Foundation
Treatments:
Valproic Acid